Effects of intramyocardial pVEGF165 delivery on regional myocardial blood flow: evidence for a spatial 'delivery-efficacy' mismatch (Q45876218)

17 December 2017

title

Effects of intramyocardial pVEGF165 delivery on regional myocardial blood flow: evidence for a spatial 'delivery-efficacy' mismatch (English)

1 reference

17 December 2017

author

Stefano Ferrari

5

1 reference

17 December 2017

author name string

Radke PW

1

1 reference

17 December 2017

Heinl-Green A

2

1 reference

17 December 2017

Frass OM

3

1 reference

17 December 2017

Griesenbach U

4

1 reference

17 December 2017

Geddes DM

6

1 reference

17 December 2017

Alton EW

7

1 reference

17 December 2017

publication date

1 August 2004

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

11

1 reference

17 December 2017

issue

16

1 reference

17 December 2017

page(s)

1249-1255

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302296

exact match

0 references

cites work

Direct myocardial revascularization and angiogenesis--how many patients might be eligible?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302296

Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302296

Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302296

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302296

Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302296

Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302296

Coronary collateral development in swine after coronary artery occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302296

Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302296

Thoracic Surgery Directors Association Award. Angiogenesis in transmyocardial revascularization: comparison of laser versus mechanical punctures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302296

Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302296

A simplification of the protein assay method of Lowry et al. which is more generally applicable

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302296

Translational physiology: porcine models of human coronary artery disease: implications for preclinical trials of therapeutic angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302296

Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302296

7 January 2021

Lack of correlation between angiographic grading of collateral and myocardial perfusion and function: implications for the assessment of angiogenic response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302296

7 January 2021

VEGF administration in chronic myocardial ischemia in pigs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302296

7 January 2021

Nitric oxide system in needle-induced transmyocardial revascularization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302296

7 January 2021

Coronary angiogenesis: detection in vivo with MR imaging sensitive to collateral neocirculation--preliminary study in pigs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302296

7 January 2021

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302296

7 January 2021

Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302296

7 January 2021

Stable labeled microspheres to measure perfusion: validation of a neutron activation assay technique

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302296

7 January 2021

Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302296

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302296

1 reference

17 December 2017

Dimensions Publication ID

1001545242

0 references

1 reference

17 December 2017